Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2010
12/02/2010US20100306868 Quadruple transgenic non-human animal
12/02/2010US20100306867 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
12/02/2010US20100306865 Penaeidin gene promoters in tiger shrimp and applications thereof
12/02/2010US20100306864 Polypeptide having enhanced effector function
12/02/2010US20100305547 Method of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease
12/02/2010US20100305306 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/02/2010US20100305199 Therapeutic regimen for treating cancer
12/02/2010US20100305198 Cationic lipids
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305193 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
12/02/2010US20100305192 Compositions and methods for short interfering nucleic acid inhibition of nav1.8
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305041 Cell permeable p18 recombinant proteins, polynucleotides encoding the same, and anticancer composition comprising the same
12/02/2010US20100305040 Production of soluble recombinant protein by pi value control of n-terminal
12/02/2010US20100305039 Production of collagen in the milk of transgenic mammals
12/02/2010US20100305034 Growth factor isoform
12/02/2010US20100305003 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
12/02/2010US20100305002 Reagents and Methods for Producing Bioactive Secreted Peptides
12/02/2010US20100304497 Fluorescent protein and chromoprotein
12/02/2010US20100304490 Method for generating a genetically modified microbe
12/02/2010US20100304489 Methods and compositions for homologous recombination in human cells
12/02/2010US20100304476 Expression of Human Serum Albumin in Plastids
12/02/2010US20100304468 Method for introducing nucleic acids into fungal cells
12/02/2010US20100304465 Recombinantly Modified Plasmin
12/02/2010US20100304464 Stable, functional chimeric cellobiohydrolases
12/02/2010US20100304461 Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli
12/02/2010US20100304460 Novel beta-galactoside-alpha2, 6-sialyltransferase, a gene encoding thereof, and a method for producing thereof
12/02/2010US20100304459 Glucose dehydrogenase polypeptides and related polynucleotides
12/02/2010US20100304445 Nucleic acid packaging system
12/02/2010US20100304438 Novel beta-glucosidase enzymes
12/02/2010US20100304434 Polypeptides having Cellulolytic Enhancing Activity and Polynucleotides Encoding Same
12/02/2010US20100304433 Polypeptides Having Protease Activity and Polynucleotides Encoding Same
12/02/2010US20100304432 Genetically modified biological cells
12/02/2010US20100304401 Ys68 gene involved in primitive hematopoiesis
12/02/2010US20100304392 Hepatitis b viral variants with reduced susceptibility to nucleoside analogs and uses thereof
12/02/2010US20100304382 Gene Defects and Mutant ALK Kinase in Human Solid Tumors
12/02/2010US20100304381 Fluorescent nucleobase conjugates having anionic linkers
12/02/2010US20100304378 Method for Detecting or Quantifying a Truncating Mutation
12/02/2010US20100304367 Compositions for real-time, single molecule sequence determination
12/02/2010US20100304189 Geobacteraceae strains and methods
12/02/2010US20100303884 Growth factor complexes and modulation of cell migration and growth
12/02/2010US20100303862 Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
12/02/2010US20100303861 Live Attenuated Vaccine Strain for Prevention of Tularemia
12/02/2010US20100303859 Vectors and method for genetic immunization
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303857 Development of a preventive vaccine for filovirus infection in primates
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303851 Immunostimulation by chemically modified rna
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303848 Vaccination method
12/02/2010US20100303845 Novel gene expressed in prostate cancer
12/02/2010US20100303843 RECOMBINANT ALLERGEN WITH REDUCED lgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
12/02/2010US20100303838 Vectors for multiple gene expression
12/02/2010US20100303829 Hiv vpr-specific t cell receptors
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303818 Dendritic cell receptor
12/02/2010US20100303814 Antibodies Against a Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
12/02/2010US20100303812 Neutralizing monoclonal antibody against human dll4
12/02/2010US20100303811 Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity.
12/02/2010US20100303803 Catenate for immunostimulation
12/02/2010US20100303776 Methods and compositions for regulated expression of multiple nucleic acids
12/02/2010US20100303775 Generation of Genetically Corrected Disease-free Induced Pluripotent Stem Cells
12/02/2010US20100303768 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
12/02/2010US20100303767 Methods for compact aggregation of dermal cells
12/02/2010US20100303762 Antifungal Polypeptides
12/02/2010US20100303759 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy
12/02/2010US20100303729 Cyanochrome fluorophores
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010US20100303724 Polypeptides, Cyclic Polypeptides and Pharmaceutical Comprising Thereof for Non Invasive Specific Imaging of Fibrosis
12/02/2010DE102009022513A1 Verfahren zum Schutz von Membranen A method for protecting membranes
12/02/2010CA2764683A1 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
12/02/2010CA2763836A1 Novel beta-glucosidase enzymes
12/02/2010CA2763641A1 Expression of recombinant proteins
12/02/2010CA2763618A1 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
12/02/2010CA2763584A1 Advanced pathogen detection and screening
12/02/2010CA2763485A1 Methods for treating cancer and non-neoplastic conditions
12/02/2010CA2763482A1 Generation of genetically corrected disease-free induced pluripotent stem cells
12/02/2010CA2763469A1 Antigen-binding proteins
12/02/2010CA2763466A1 Fibromodulin peptide
12/02/2010CA2763464A1 Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
12/02/2010CA2763354A1 Sonication cartridge for nucleic acid extraction
12/02/2010CA2763115A1 Stim2-mediated capacitive calcium entry
12/02/2010CA2762934A1 Cdc45l peptides and vaccines including the same
12/02/2010CA2762556A1 A dna cassette, binary vector, and strain of a. tumefaciens and a method of producing cereal plant of increased productivity and/or root mass
12/02/2010CA2762432A1 Light-regulated promoters
12/02/2010CA2762303A1 Differentiation therapy for sarcomas
12/02/2010CA2762204A1 Increased seed oil and abiotic stress tolerance mediated by hsi2
12/02/2010CA2762203A1 Simian adenovirus 41 and uses thereof
12/02/2010CA2761817A1 Production of glycoproteins
12/02/2010CA2758356A1 A collection and methods for its use
12/01/2010EP2256486A1 Probe reagent for measuring oxidative stress
12/01/2010EP2256218A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
12/01/2010EP2256213A1 Asynchronous primed PCR
12/01/2010EP2256211A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media
12/01/2010EP2256207A1 Sugar and lipid metabolism regulators in plants VI
12/01/2010EP2256206A1 Method and gene for imparting or enhancing nonspecific adherence and/or aggregability to microorganism
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256203A1 IL-23 and its receptor; related reagents and methods
1 ... 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 ... 4023